The effect of non-steroidal anti-inflammatory drugs and other commonly used non-narcotic analgesics on blood pressure level in adults

Journal of Hypertension

Volumn 24, Issue 8, 2006, Pages 1457-1469

  Wilson, Sarah L ^a   Poulter, Neil R ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Aspirin; Blood pressure; Hypertension; Ibuprofen; Non narcotic analgesics; Non steroidal anti inflammatory drugs; Paracetamol; Review

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ANALGESIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FELODIPINE; IBUPROFEN; INDOMETACIN; LUMIRACOXIB; NAPROXEN; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIROXICAM; RENIN; SULINDAC;

ABSENCE OF SIDE EFFECTS; ANAMNESIS; ARTERIAL PRESSURE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DISEASE EXACERBATION; DRUG MECHANISM; FAMILY HISTORY; FOLLOW UP; HUMAN; HYPERTENSION; LONG TERM CARE; LOW DRUG DOSE; OSTEOARTHRITIS; PREDICTION; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEX DIFFERENCE; SMOKING; STATISTICAL SIGNIFICANCE; TREATMENT DURATION;

EID: 33746777182     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000239278.82196.a5     Document Type: Review

References (32)

1. Prescription Pricing Authority. Prescription Cost Analysis: England 2004. www.dh.gov.uk [Accessed 12 August 2005].
2. British Medical Association and the Royal Pharmaceutical Society of Great Britain. British national formulary. London: BMA and RPSGB; 49 March 2005.
3. Williams B, Poulter NR, Brown MJ, Davids M, McInnes GT, Potter JF, et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, BHS IV. J Hum Hypertens 2004; 18:139-185.
4. Mulkerrin EC, Clark BA, Epstein FH. Increased salt retention and hypertension from non-steroidal agents in the elderly. QJM 1997; 90:411-415.
5. Murray MD, Lazaridis EN, Brizendine E, Haa K, Becker P, Brater DC. The effect of nonsteroidal anti-inflammatory drugs on electrolyte homeostasis and blood pressure in young and elderly persons with and without renal insufficiency. Am J Med Sci 1997; 314:80-88.
6. Frishman WH. Effects of nonsteroidal anti-inflammatory drug therapy on blood pressure and peripheral edema. Am J Cardiol 2002; 89 (suppl):18D-25D.
7. Mene P, Pugliese F, Patrono C. The effects of nonsteroidal antiinflammatory drugs on human hypertensive vascular disease. Semin Nephrol 1995; 15:244-252.
8. Dedier J, Stampfer MJ, Hankinson SE, Willett WC, Speizer FE, Curhan GC. Nonnarcotic analgesic use and the risk of hypertension in US women. Hypertension 2002; 40:604-608.
9. Curhan GC, Willett WC, Rosner B, Stampfer MJ. Frequency of analgesic use and risk of hypertension in younger women. Arch Intern Med 2002; 162:2204-2208.
10. McKenney JM, Wright JT, Goodman RP, Cooper L, Yunker N, Lambert C. Effect of high dose ibuprofen on 24 hour blood pressure in healthy women. Drug Intell Clin Pharmacy 1987; 21:517-520.
11. Pope JE, Anderson JJ, Felson DT. A meta-analysis of the effects of nonsteriodal anti-inflammatory drugs on blood pressure. Arch Intern Med 1993; 153:477-484.
12. Johnson AG, Nguyen TV, Day RO. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med 1994; 121:289-300.
13. Forman JP, Stampfer MJ, Curhan GC. Non-narcotic analgesic dose and risk of incident hypertension in US women. Hypertension 2005; 46:500-507.
14. Kurth T, Hennekens CH, Sturmer T, Sesso HD, Glynn RJ, Buring JE, et al. Analgesic use and risk of subsequent hypertension in apparently healthy men. Arch Intern Med 2005; 165:1903-1909.
15. Wolfe F, Zhao S, Reynolds M, Pettitt D. Blood pressure destabilization and edema among 8538 users of celecoxib, rofecoxib and nonselective nonsteroidal anti-inflammatory drugs (NSAID) and nonusers of NSAID receiving ordinary clinical care. J Rheumatol 2004; 31:1143-1151.
16. Gurwitz JH, Avorn J, Bohn RL, Glynn RJ, Monane M, Mogun H. Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy. JAMA 1994; 272:781-786.
17. Sheridan R, Montgomery AA, Fahey T. NSAID use and BP in treated hypertensives: a retrospective controlled observational study. J Hum Hypertens 2005; 19:445-450.
18. Farkouh ME, Kirshner H, Harrington RA, Ruland S, Verheugt FWA, Schnitzer TJ, et al., On behalf of the TARGET Study Group. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial. Lancet 2004; 364:675-684.
19. Houston MC, Weir M, Gray J, Ginsberg D, Szeto C, Kaihlenen PM, et al. The effect of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil. Arch Intern Med 1995; 155:1049-1054.
20. Polonia J, Boaventura I, Gama G, Camoes I, Bernardo F, Andrade P, et al. Influence of non-steroidal anti-inflammatory drugs on renal function and 24hr ambulatory blood pressure-reducing effects of enalapril and nifedipine gastrointestinal therapeutic system in hypertensive patients. J Hypertens 1995; 13:925-931.
21. Morgan T, Anderson A. Interaction of indomethacin with felodipine and enalapril. J Hypertens 1993; 1 (suppl 5):S334-S338.
22. Morgan TO, Anderson AIE, MacInnis RJ. ACE inhibitors, beta-blocking drugs, calcium channel blocking drugs and diuretics for the control of elevated systolic blood pressure in the elderly: a double blind crossover study in previously untreated patients. Am J Hypertens 2001; 14:241-247.
23. Hawkins MM, Seelig CB. A case of acute renal failure induced by the co-administration of NSAIDs and captopril. North Carolina Med J 1990; 51:291-292.
24. Handler J. Drug induced hypertension. J Clin Hypertens 2003; 5:83-85.
25. Primatesta P, Poulter NR. Hypertension management and control among English adults aged 65 years and older in 2000 and older in 2000 and 2001. J Hypertens 2004; 22:1093-1098.
26. Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V. AHA/ACC scientific statement; assessment of cardiovascular risk by use of multiple-risk factor assessment equations. J Am Coll Cardiol 1999; 34:1348-1359.
27. Chalmers JP, West MJ, Wing LMH, Bune AJC, Graham JR. Effects of Indomethacin, sulindac, naproxen, aspirin and paracetamol in treated hypertensives. Clin Exp Hypertens 1984; A6:1077-1093.
28. Hermida RC, Ayala DE, Calvo C, Lopez JE, Fernandez JR, Mojon A, et al. Administration time-dependent effects of aspirin on blood pressure in untreated hypertensive patients. Hypertension 2003; 41:1259-1267.
29. Nawarskas JJ, Townsend RR, Cirigliano MD, Spinler SA. Effect of aspirin on blood pressure in hypertensive patients taking enalapril or losartan. Am J Hypertens 1999; 12:784-789.
30. Avanzini F, Palumbo G, Alli C, Roncaglioni MC, Ronchi E, Cristofari M, et al. Effects of low-dose aspirin on clinic and ambulatory blood pressure in treated hypertensive patients. Am J Hypertens 2000; 13:611-616.
31. Zanchetti A, Hansson L, Leonetti G, Rahn K-H, Ruilope L, Warnold I, et al. Low-dose aspirin does not interfere with the blood pressure-lowering effects of antihypertensive therapy. J Hypertens 2002; 20:1015-1022.
32. Weir RJ. Oral contraceptives, hormone replacement therapy and hypertension. In: Swales JD, editor. Textbook of hypertension. Oxford: Blackwell Scientific; 1994. pp. 904-992.